| JOURNAL HOME | CME HOME | THIS MONTH | PAST ISSUES | ETOC | COLLECTIONS |
| AUTHORS | REVIEWERS | EDITORIAL BOARD | FEEDBACK | RSS | HELP |
| ||||||||||||||
| ||||||||||||||
|
|
|
|
||||||||||||
|
||||||||||||||
Departments of
*Anesthesiology and Critical Care,
Blood Bank, and
Orthopedic Surgery, Meir Hospital, Kfar Sava, The Sackler School of Medicine, Tel Aviv University, Tel Aviv, Israel
Address correspondence and reprint requests to Robert Jedeikin, BSc, MB ChB, FFA(SA), Department of Anesthesiology and Intensive Care, Meir Hospital, Kfar Saba 44281, Israel.
Both acute normovolemic hemodilution (NVHD) and tranexamic acid (TA) are potentially useful allogeneic blood conservation strategies after total knee replacement. However, the relative efficacy of these blood-sparing techniques is unknown. Therefore, to compare the postoperative allogeneic blood sparing of NVHD and TA after total knee replacement, we investigated 40 patients in a prospective, single-blinded study protocol. In Group TA, 30 min before deflating the limb tourniquet, an IV infusion of TA, 15 mg/kg, was administered over a 30-min period. Thereafter, a constant IV infusion of 10 mg · kg-1 · hr-1 was administered until 12 h after deflation of the limb tourniquet. Before induction of anesthesia, NVHD patients were bled to a target hematocrit of approximately 28%. Intravascular blood volume was maintained with lactated Ringer’s solution. All autologous blood was transfused at the end of the surgery. Postoperatively, hematocrit was measured daily. In all cases, a hematocrit <27% was the postoperative transfusion trigger. Before discharge, deep vein thrombosis was excluded by Echo Doppler. Three months after surgery, the incidence of delayed thrombo-embolic events was assessed. The two groups were demographically comparable. In Group NVHD, 843 mL ± 289 of autologous blood was removed. Despite autologous blood transfusion, during the early postoperative period and until the third postoperative day, the NVHD group had significantly (P < 0.01) lower mean hematocrits when compared with the TA group. Thereafter, because of a significantly (P < 0.0008) greater allogeneic blood requirement in the NVHD group, no statistically significant difference in mean hematocrit recordings was noted among the groups. Blood accumulation in the surgical drain 12 h postoperatively, was significantly (P < 0.0008) higher in the NVHD group (259 mL ± 156) when compared with the TA group (110 mL ± 62). Significantly (P < 0.0008) more allogeneic blood was transfused in the NVHD group (19 U/13 patients) when compared with the TA group (2 U/2 patients). No abnormal Echo Doppler studies were reported. During the 3-mo follow-up period, a deep vein thrombosis and pulmonary embolus were documented in one patient in the NVHD group. We conclude that perioperative hemodynamic stability and allogeneic blood sparing is superior after tranexamic acid administration when compared with normovolemic hemodilution.
Implications: For total knee replacement, when compared with normovolemic hemodilution, tranexamic acid administration is associated with superior perioperative hemodynamic stability and allogeneic blood sparing.
This article has been cited by other articles:
|
|
 |
|
  R. Lemaire Strategies for blood management in orthopaedic and trauma surgery J Bone Joint Surg Br, September 1, 2008; 90-B(9): 1128 - 1136. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 E. Zohar, M. Ellis, N. Ifrach, A. Stern, O. Sapir, and B. Fredman The Postoperative Blood-Sparing Efficacy of Oral Versus Intravenous Tranexamic Acid After Total Knee Replacement Anesth. Analg., December 1, 2004; 99(6): 1679 - 1683. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 E. Lemay, J. Guay, C. Cote, and A. Roy Tranexamic acid reduces the need for allogenic red blood cell transfusions in patients undergoing total hip replacement: [L'acide tranexamique reduit les besoins de transfusion sanguine allogenique chez les patients devant subir une arthroplastie totale de la hanche] Can J Anesth, January 1, 2004; 51(1): 31 - 37. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. M. Engel, T. Hohaus, R. Ruwoldt, T. Menges, I. Jurgensen, and G. Hempelmann Regional Hemostatic Status and Blood Requirements After Total Knee Arthroplasty With and Without Tranexamic Acid or Aprotinin Anesth. Analg., March 1, 2001; 92(3): 775 - 780. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. Innerhofer, G. Kuhbacher, W. Schobersberger, E. Zohar, B. Fredman, M. Ellis, and R. Jedeikin Antifibrinolytic Therapy Reduces Blood Loss in Knee Replacement Surgery Response Anesth. Analg., August 1, 2000; 91(2): 497 - 498. [Full Text] [PDF]
|
|
|
|
|
|
K. Karkouti, E. Zohar, B. Fredman, M. Ellis, and R. Jedeikin Is Tranexamic Acid Indicated for Total Knee Replacement Surgery? Response Anesth. Analg., April 1, 2000; 91(1): 244 - 245. [Full Text] [PDF]
|
|
|
